Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Anxiety and treatment adherence among glaucoma patients during COVID-19 pandemic and earthquakes in Croatia (CROSBI ID 315400)

Prilog u časopisu | izvorni znanstveni rad

Lešin Gaćina, Dina ; Jandroković, Sonja ; Marčinko, Darko ; Škegro, Ivan ; Vidas Pauk, Sania ; Tomić, Martina ; Škegro, Bernarda ; Barišić Kutija, Marija ; Ivkić, Petra Kristina Anxiety and treatment adherence among glaucoma patients during COVID-19 pandemic and earthquakes in Croatia // Psychiatria Danubina, 34 (2022), 2; 348-355. doi: 10.24869/psyd.2022.348

Podaci o odgovornosti

Lešin Gaćina, Dina ; Jandroković, Sonja ; Marčinko, Darko ; Škegro, Ivan ; Vidas Pauk, Sania ; Tomić, Martina ; Škegro, Bernarda ; Barišić Kutija, Marija ; Ivkić, Petra Kristina

engleski

Anxiety and treatment adherence among glaucoma patients during COVID-19 pandemic and earthquakes in Croatia

Background: The COVID-19 epidemic and earthquakes in Croatia during 2020 suddenly disrupted everyday life and caused psychological disturbances in population. The purpose of the present study was to assess the prevalence of anxiety symptoms and the level of treatment adherence in glaucoma patients during the pandemic. The paper also aimed to evaluate the correlation between anxiety symptoms, treatment adherence and treatment outcomes in the studied cohort. Subjects and methods: This cross-sectional study was conducted among primary open-angle glaucoma (POAG) patients at the Department of Ophthalmology, Zagreb University Hospital Center, during one year. The Beck Anxiety Inventory (BAI) was used to measure the level of anxiety symptoms. Treatment adherence was estimated by the Culig adherence scale (CAS). Glaucoma damage was determined for each patient from the level of structural and functional impairment of the worse eye, by retinal nerve fiber layer (RNFL) thickness and mean defect (MD), respectively. Statistical analyses were performed, with a P value of less than 0.05 considered being statistically significant. Results: This study included 113 POAG patients, with a mean age of 65.89 years. The median of the BAI total score in all patients was 10. According to the CAS, 60.2% of patients were non- adherent to glaucoma treatment during the COVID-19 outbreak. The BAI total score was significantly negatively related to adherence to local glaucoma treatment (p<0.001). A significant negative association was also observed between adherence and MD (p=0.017), while no correlation was found between adherence and RNFL thickness (p=0.228). Conclusion: Considerable proportion of patients with glaucoma have shown non-adherence to treatment during the COVID-19 pandemic. Anxiety severity was associated with lower adherence, thus indirectly influencing therapeutics outcomes. Special consideration should be given to the strategies promoting mental health and interventions focusing on treatment adherence in glaucoma patients in a time of emergencies.

glaucoma ; treatment adherence ; anxiety ; visual impairment ; COVID-19 pandemic

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

34 (2)

2022.

348-355

objavljeno

0353-5053

1849-0867

10.24869/psyd.2022.348

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost